Cargando…
Chimaeric antigen receptor T-cell therapy for tumour immunotherapy
Chimaeric antigen receptor (CAR) T-cell therapies, as one of the cancer immunotherapies, have heralded a new era of treating cancer. The accumulating data, especially about CAR-modified T cells against CD19 support that CAR T-cell therapy is a highly effective immune therapy for B-cell malignancies....
Autores principales: | Sha, Huan-huan, Wang, Dan-dan, Yan, Da-li, Hu, Yong, Yang, Su-jin, Liu, Si-wen, Feng, Ji-feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270315/ https://www.ncbi.nlm.nih.gov/pubmed/28053197 http://dx.doi.org/10.1042/BSR20160332 |
Ejemplares similares
-
Radial Symmetry in a Chimaeric Glutamate Receptor Pore
por: Wilding, Timothy J, et al.
Publicado: (2014) -
Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.
por: Zoubek, A., et al.
Publicado: (1994) -
The provenance of cells in sarcomas induced in chimaeric mice.
por: Ansell, J. D., et al.
Publicado: (1986) -
Design of a chimaeric antigen and its use in the detection of IgG antibodies against rubella virus
por: Xing, Wenyue, et al.
Publicado: (2022) -
Precise targeted integration by a chimaeric transposase zinc-finger fusion protein
por: Feng, Xiaofeng, et al.
Publicado: (2010)